For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Sabra Healthcare REIT Inc (NASDAQ: SBRA) was $19.55 for the day, down -0.36% from the previous closing price of $19.62. In other words, the price has decreased by -$0.36 from its previous closing price. On the day, 3.55 million shares were traded. SBRA stock price reached its highest trading level at $19.97 during the session, while it also had its lowest trading level at $19.52.
Ratios:
Our analysis of SBRA’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 46.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.84. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 0.89. In the meantime, Its Debt-to-Equity ratio is 0.93 whereas as Long-Term Debt/Eq ratio is at 0.92.
On January 07, 2025, JMP Securities Upgraded its rating to Mkt Outperform which previously was Mkt Perform but kept the price unchanged to $20.
Mizuho Downgraded its Outperform to Neutral on December 05, 2024, while the target price for the stock was maintained at $20.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 20 ’25 when FOSTER MICHAEL J sold 11,000 shares for $18.22 per share. The transaction valued at 200,376 led to the insider holds 64,725 shares of the business.
Michael J. Foster bought 11,000 shares of SBRA for $192,500 on May 15 ’25. On Feb 24 ’25, another insider, Cusack Catherine, who serves as the Director of the company, bought 1,500 shares for $15.92 each. As a result, the insider paid 23,880 and bolstered with 60,583 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBRA now has a Market Capitalization of 4687933440 and an Enterprise Value of 7075167744. As of this moment, Sabra’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.71, and their Forward P/E ratio for the next fiscal year is 25.16. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.85. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.47 while its Price-to-Book (P/B) ratio in mrq is 1.73. Its current Enterprise Value per Revenue stands at 9.639 whereas that against EBITDA is 16.074.
Stock Price History:
The Beta on a monthly basis for SBRA is 0.84, which has changed by 0.18269813 over the last 52 weeks, in comparison to a change of 0.1513431 over the same period for the S&P500. Over the past 52 weeks, SBRA has reached a high of $19.99, while it has fallen to a 52-week low of $15.60. The 50-Day Moving Average of the stock is 6.02%, while the 200-Day Moving Average is calculated to be 10.53%.
Shares Statistics:
SBRA traded an average of 2.55M shares per day over the past three months and 2750440 shares per day over the past ten days. A total of 239.79M shares are outstanding, with a floating share count of 235.39M. Insiders hold about 1.84% of the company’s shares, while institutions hold 98.56% stake in the company. Shares short for SBRA as of 1753920000 were 19218337 with a Short Ratio of 7.54, compared to 1751241600 on 19864948. Therefore, it implies a Short% of Shares Outstanding of 19218337 and a Short% of Float of 11.2799995.
Dividends & Splits
With its trailing 12-month dividend rate of 1.2, SBRA has a forward annual dividend rate of 1.17. Against a Trailing Annual Dividend Yield of 0.061162084The stock’s 5-year Average Dividend Yield is 8.29. The current Payout Ratio is 223.55% for SBRA, which recently paid a dividend on 2025-08-15 with an ex-dividend date of 2025-08-15. Stock splits for the company last occurred on 2010-11-16 when the company split stock in a 1:3 ratio.
Earnings Estimates
The stock of Sabra Healthcare REIT Inc (SBRA) is currently in the spotlight, with 1.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $0.19, with high estimates of $0.19 and low estimates of $0.19.
Analysts are recommending an EPS of between $0.82 and $0.81 for the fiscal current year, implying an average EPS of $0.81. EPS for the following year is $0.78, with 2 analysts recommending between $0.8 and $0.76.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 2 analysts. It ranges from a high estimate of $192.43M to a low estimate of $188.1M. As of the current estimate, Sabra Healthcare REIT Inc’s year-ago sales were $178MFor the next quarter, 2 analysts are estimating revenue of $192.29M. There is a high estimate of $194.08M for the next quarter, whereas the lowest estimate is $190.5M.
A total of 3 analysts have provided revenue estimates for SBRA’s current fiscal year. The highest revenue estimate was $759.21M, while the lowest revenue estimate was $747M, resulting in an average revenue estimate of $753.71M. In the same quarter a year ago, actual revenue was $703.24MBased on 6 analysts’ estimates, the company’s revenue will be $803.19M in the next fiscal year. The high estimate is $945.41M and the low estimate is $736.47M.
